Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.1M Buy
11,500
+5,200
+83% +$470K ﹤0.01% 3486
2014
Q2
$576K Buy
6,300
+3,300
+110% +$296K ﹤0.01% 4079
2014
Q1
$264K Sell
3,000
-2,100
-41% -$184K ﹤0.01% 4889
2013
Q4
$473K Sell
5,100
-3,200
-39% -$288K ﹤0.01% 4406
2013
Q3
$678K Sell
8,300
-4,800
-37% -$405K ﹤0.01% 3777
2013
Q2
$1.09M Buy
+13,100
New +$1.13M ﹤0.01% 3235

Other funds holding CLX

UBS's CLX Position: Q3 2014 in Review

UBS reduced its Clorox (CLX) stake by 9.1% in Q3 2014, selling an estimated $9.96M and leaving 1,098,136 shares worth $105M. The position accounts for 0.08% of the portfolio, ranked #255.

UBS first reported a position in CLX in Q2 2013 and has held it in 6 quarters since. The position peaked at $277M in Q4 2013. 676 funds tracked by Wall St. Rank hold CLX as of Q3 2014.

  • UBS held 1,098,136 shares of Clorox worth $105M as of Q3 2014.
  • UBS sold 110,171 Clorox shares in Q3 2014, an estimated $9.96M.
  • Clorox made up 0.08% of UBS's portfolio in Q3 2014, its #255 holding.
  • UBS first reported a position in Clorox in Q2 2013 and has held it in 6 quarters since.
  • UBS's Clorox position peaked at $277M in Q4 2013.
  • 676 funds tracked by Wall St. Rank held Clorox as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.